Patent details

EP3204424 Title: COMBINATION THERAPY OF C-C CHEMOKINE RECEPTOR-9 (CCR9) INHIBITORS AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

Basic Information

Publication number:
EP3204424
PCT Application Number:
US2015054077
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP158489161
PCT Publication Number:
WO2016057424
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY OF C-C CHEMOKINE RECEPTOR-9 (CCR9) INHIBITORS AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
French Title of Invention:
POLYTHÉRAPIE À BASE D'INHIBITEURS DU RÉCEPTEUR 9 DE CHIMIOKINE C-C (CCR9) ET D'ANTICORPS BLOQUANTS ANTI-INTÉGRINE ALPHA4BETA7 POUR LE TRAITEMENT D'UNE MALADIE INFLAMMATOIRE DE L'INTESTIN
German Title of Invention:
KOMBINATIONSTHERAPIE MIT C-C-CHEMOKINREZEPTOR-9-INHIBITOREN UND ALPHA4BETA7-INTEGRIN-BLOCKERANTIKÖRPERN ZUR BEHANDLUNG VON ENTZÜNDLICHEN DARMERKRANKUNGEN
SPC Number:

Dates

Filing date:
05/10/2015
Grant date:
29/11/2023
EP Publication Date:
16/08/2017
PCT Publication Date:
14/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/11/2023
EP B1 Publication Date:
29/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/11/2023
 
 

Name:
ChemoCentryx, Inc.
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, United States (US)

Inventor

1

Name:
ZHANG, Penglie
Address:
United States (US)

2

Name:
EBSWORTH, Karen
Address:
United States (US)

3

Name:
TAN, Joanne
Address:
United States (US)

4

Name:
ZENG, Yibin
Address:
United States (US)

5

Name:
WANG, Yu
Address:
United States (US)

Priority

Priority Number:
201462060454 P
Priority Date:
06/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61K 39/395; A61K 31/517; A61K 47/14; A61P 1/00; A61K 31/4412;

Publication

European Patent Bulletin

Issue number:
202348
Publication date:
29/11/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages